Healthcare AI Doesn’t Have an Innovation Problem. It Has an Adoption Problem

Healthcare doesn’t need another explanation of what AI could do. It needs a clearer understanding of what it takes to move AI from potential to adoption, and from adoption to quality care.

That’s no small feat. As new AI solutions flood the market, building the technology is no longer the hardest part. Earning the confidence to use it is.

This theme recurred during Newsweek’s AI Health Summit on September 23. From the main stage, health system leaders, academic medical centers and healthcare innovators shared compelling examples of AI in action, from earlier detection of critical conditions to faster clinical trial screening. 

But beyond the technology and results, each impressive in its own right, the stories signaled a bigger question: What makes a complex healthcare organization choose one solution over seemingly endless alternatives, and what gives its leaders the confidence to move forward?

The story is people, not platforms

The summit started with stories focused on human impact, not technical capabilities. Mount Sinai Health System CEO Dr. Brendan Carr shared research using AI to identify signs of potential neurological dysfunction in infants. Tampa General Hospital CEO John Couris described how AI helps clinicians anticipate sepsis, contributing to more than 1,000 lives saved. And Paradigm Health CEO Kent Thoelke explained how AI-enabled screening can help identify clinical trial candidates, including patients outside major academic research centers.

Each example illustrated a different application of AI, but all shared common threads: identifying risk earlier, helping clinicians act sooner, and expanding opportunities for patients.

These are the stories healthcare leaders need to hear to adopt with confidence.

For AI developers, it can be tempting to lead with technical capabilities. But capabilities alone don’t tell the human story. Health systems need to understand how a solution will affect both those delivering care and those receiving it.

The most effective messaging connects these dots, and does so strategically. 

Attention is limited, but companies can break through by telling stories that stick and reaching decision-makers where they already are. That means making the complex compelling: keeping the human story at the center, backing it with evidence, and making the science approachable. Through trusted media, relevant channels, and industry conversations, strategic communications build awareness and credibility, often before decision-makers actively begin evaluating solutions

Proof outweighs promises 

A powerful story earns attention, but proof is what drives adoption.

In an emerging and crowded market, even compelling claims need credible evidence to support them. For healthcare decision-makers, that means looking beyond what a company says about its solution to the research, results, and real-world experiences that validate its value.

That same scrutiny shapes healthcare reporting. In an interview with Antenna, Newsweek healthcare editor Alexis Kayser described the challenge of identifying a source of truth and her reliance on third-party, peer-reviewed research.

For companies, this reinforces the importance of independent perspectives in establishing trust. Peer-reviewed publications, credible media coverage, and partner testimonials each offer a different lens through which healthcare decision-makers can evaluate the evidence and build confidence in adoption.

Governance, transparency, and ongoing monitoring were also central to the conversation. Health system leaders want to know that humans stay involved in decisions, who is accountable, and how performance will be evaluated over time, not just at launch.

These answers shouldn’t live in technical documentation alone or surface only when concerns arise. Thought leadership creates an opportunity to put evidence, safeguards, and real-world performance at the center of the story, demonstrating how the technology addresses the realities of care. 

Shift from pilot to practice: build buy-in early

One soundbite from the summit lingered long after the panel wrapped: “Beware the word pilot.” Couris explained how pilots can become an indefinite testing ground rather than a path to meaningful implementation. The goal isn’t to keep sampling solutions. It’s to make a deliberate choice and commit to making the right one work.

Getting there takes more than evaluating the technology itself. In Couris’s example, a recommendation from a trusted health system partner opened the door. From there, he involved the internal team to build buy-in and understand workflow implications before moving forward.

This offered a healthy reminder that reputation matters and word of mouth remains powerful. A trusted recommendation still needs clear evidence of value to support it, but awareness and reputation can open the door to adoption.

Where communicators come in: telling the right story

As AI moves from experimentation to implementation, the organizations that stand out won’t necessarily have the most impressive technology. They’ll be the ones that earn trust, and healthcare communicators play a pivotal role in getting there: showing why a solution matters, who it serves, and how it fits into clinical workflows.

This means getting the right message to the right people. 

For AI companies, that means tailoring the story to each audience, from clinical leaders to frontline clinicians. For health systems, it means turning implementation experience into proof of what works, then sharing it with providers, patients, and stakeholders. It means knowing where to share that story strategically.

It’s all about people

The summit may have wrapped, but the work is just beginning. AI adoption isn’t about products. It’s about people. People build the technology, champion it, bring it into health systems, make it work in practice, and validate whether it delivers. Ultimately, the measure of progress will not be the amount of AI adoption; it will be whether it helps people live better lives.

‍